Blood test may spot returning prostate cancer earlier
NCT ID NCT07334275
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special blood test can find tiny bits of tumor DNA left after prostate cancer surgery. The goal is to see if this test can better predict if the cancer will come back early in high-risk patients. About 50 men with high-risk prostate cancer will give blood samples before and after surgery to check for this DNA.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Prosper Prostate Cancer Clinics
RECRUITINGNijmegen, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?